These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20621945)

  • 21. [Brain atrophy and cognitive disorder in multiple sclerosis].
    Pál E; Kosztolányi P; Perlaky P
    Orv Hetil; 2002 Dec; 143(48):2681-5. PubMed ID: 12501577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas.
    Gehring K; Aaronson NK; Gundy CM; Taphoorn MJ; Sitskoorn MM
    J Int Neuropsychol Soc; 2011 Mar; 17(2):256-66. PubMed ID: 21205412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rehabilitation of executive dysfunction: a controlled trial of an attention and problem solving treatment group.
    Miotto EC; Evans JJ; de Lucia MC; Scaff M
    Neuropsychol Rehabil; 2009 Aug; 19(4):517-40. PubMed ID: 18766984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Executive function needs to be targeted to improve social functioning with Cognitive Remediation Therapy (CRT) in schizophrenia.
    Penadés R; Catalán R; Puig O; Masana G; Pujol N; Navarro V; Guarch J; Gastó C
    Psychiatry Res; 2010 May; 177(1-2):41-5. PubMed ID: 20381164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The possibilities of neuropsychological rehabilitation in multiple sclerosis].
    Rosti-Otajärvi E; Hämäläinen P
    Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.
    Daniels C; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2010 Aug; 25(11):1583-9. PubMed ID: 20589868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
    Tiemann L; Penner IK; Haupts M; Schlegel U; Calabrese P
    Mult Scler; 2009 Oct; 15(10):1164-74. PubMed ID: 19667010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does slowed processing speed account for executive deficits in multiple sclerosis? Evidence from neuropsychological performance and structural neuroimaging.
    Leavitt VM; Wylie G; Krch D; Chiaravalloti N; DeLuca J; Sumowski JF
    Rehabil Psychol; 2014 Nov; 59(4):422-8. PubMed ID: 25133903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial.
    van Uffelen JG; Chinapaw MJ; van Mechelen W; Hopman-Rock M
    Br J Sports Med; 2008 May; 42(5):344-51. PubMed ID: 18308888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
    van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
    Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive rehabilitation in multiple sclerosis.
    Brissart H; Leroy M; Morele E; Baumann C; Spitz E; Debouverie M
    Neurocase; 2013; 19(6):553-65. PubMed ID: 22853712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goal management training of executive functions in patients with spina bifida: a randomized controlled trial.
    Stubberud J; Langenbahn D; Levine B; Stanghelle J; Schanke AK
    J Int Neuropsychol Soc; 2013 Jul; 19(6):672-85. PubMed ID: 23575309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence.
    Turner TH; LaRowe S; Horner MD; Herron J; Malcolm R
    J Subst Abuse Treat; 2009 Dec; 37(4):328-34. PubMed ID: 19394790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.